Since the sudden spread of COVID-19, healthcare organizations are faced with an entirely new normal for patient diagnosis, treatment and monitoring, as well as clinical trials. What does this mean for treatment of this and other conditions?
Our panel of experts from Cancer Treatment Centers of America, everis and NTT DATA Services examine the changes as a result of the novel coronavirus, exploring the ways technology that can help us better understand science and get closer to our patients.
Here’s what you will learn:
We’ll also highlight cancer and bipolar disorder use cases and share a recent study.
Chris Cournoyer, CareDx and Spok Communications Board Member